Eye Cells May Have Been Rejuvenated for the First Time in People

An experimental therapy addresses aging cells in the eye that can lead to vision loss.

一项针对青光眼患者的1期临床试验首次在人体内用三个山中因子对眼细胞进行部分重编程，两名受试者出现视野改善的早期迹象。该疗法基于David Sinclair的表观遗传噪声理论，目前主要目标是验证安全性。